WASHINGTON, DC – An independent advisory committee for the Food and Drug Administration (FDA) will meet on July 13 to review a new Alzheimer’s drug, a decision that holds profound implications for millions of patients and their families.
SILVER SPRING, MD – An advisory committee for the U.S. Food and Drug Administration is set to review a potentially life-altering gene therapy for children with sickle cell disease, a decision that could reshape treatment for the inherited blood disorder.
NATIONWIDE – The U.S. Food and Drug Administration (FDA) has elevated an ongoing tomato recall to a Class I designation, its highest level of warning, due to a significant risk of Salmonella contamination that could lead to serious adverse health consequences or death. This expanded recall primarily affects tomatoes distributed in the southeastern United States, with […]
Washington D.C. – On April 22, 2025, in Washington D.C., U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., alongside the U.S. Food and Drug Administration (FDA), announced a sweeping initiative to phase out petroleum-based synthetic dyes from the nation’s food supply, marking a significant step in the ‘Make America Healthy […]
